Industry reports
Editor highlights

Publication dates

Leukemia Research Reports, April 2014

You might be interested in: cancer, nucleic acid testing, flow cytometry, more »


 

1-10 of about 200 reports for Leukemia
The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2014
  • by Global Data

... Or business research. - Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc ...

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Information and data relating to the clinical trials on refractory acute myeloid leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Briefing pertaining to the number of trials for the key drugs for treating refractory chronic lymphocytic leukemia (cll). This report is built using data and information sourced from proprietary databases ...

Refractory Leukemia Global Clinical Trials Review, H1, 2014

Refractory Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... On refractory leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease ...

Mast Cell Leukemia Global Clinical Trials Review, H1, 2014

Mast Cell Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Cell leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease ...

Leukemia Drug Pipeline Update 2014

Leukemia Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... leukemia drug pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 268 different targets. All included targets have been cross ...

Leukemia Drug Pathway Analyzer 2014

Leukemia Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the leukemia ...

Analytical Tool - Hematological Cancers

Analytical Tool - Hematological Cancers

  • $ 8 925
  • Industry report
  • March 2014
  • by Bioseeker

... For optimizing the leukemia pipeline: from research and development to marketa support tool for optimizing the lymphoma pipeline: from research and development to market ...

Analytical Tool - Leukemia

Analytical Tool - Leukemia

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

... Analytical tool - leukemia "analytical tool - leukemia" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in leukemia r&d and business development ...

Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014

Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Provides elemental information and data relating to the clinical trials on juvenile myelomonocytic leukemia (jmml). It includes an overview of the trial numbers and their recruitment status as per the site ...


» Read our Company Profiles

8 Companies for Leukemia

Celgene Corp.

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

Bristol-Myers Squibb Co.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.